FindMyRecallSubscribe
Class I: serious health riskTerminated

KVK-Tech Atovaquone Oral Suspension Recall

Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd

KVK-Tech, Inc. · Newtown, PA

Risk level
Class I
Reported by FDA
Sep 1, 2021
Recall ID
D-0772-2021
Check your lot numberHow we source this data

Summary

KVK-Tech recalled Atovaquone Oral Suspension starting Jul 2, 2021. The FDA classified it as Class I (serious health risk) and published enforcement report D-0772-2021 on Sep 1, 2021. Reason: Temperature abuse: the firm received customer complaints of unusual grittiness in the product. Status: Terminated.

Why it was recalled

Temperature abuse: the firm received customer complaints of unusual grittiness in the product.

Product description

Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.

Lot numbers, UPCs & expiration codes

Batch # 16653A, 16654A, Exp 12/2022

Where it was sold

Product was distributed to one distributor who may have further distributed Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0772-2021
Classification
Class I
Status
Terminated
Recall initiated
Jul 2, 2021
FDA report date
Sep 1, 2021
Quantity
1,692 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
KVK-Tech, Inc.

Original FDA data

Every field from FDA enforcement report D-0772-2021, exactly as published.

Show all FDA fields
City
Newtown
State
PA
Status
Terminated
Country
United States
Event ID
88220
Address
110 Terry Dr
Code information
Batch # 16653A, 16654A, Exp 12/2022
Postal code
18940-3427
Report date
Sep 1, 2021
Product type
Drugs
Recall number
D-0772-2021
Classification
Class I
Recalling firm
KVK-Tech, Inc.
Product quantity
1,692 bottles
Termination date
May 23, 2022
Reason for recall
Temperature abuse: the firm received customer complaints of unusual grittiness in the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.
Distribution pattern
Product was distributed to one distributor who may have further distributed Nationwide in the USA.
Recall initiation date
Jul 2, 2021
Initial firm notification
Letter
Center classification date
Aug 26, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0772-2021, published Sep 1, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls